cells were incubated in duplicate at three concentrations of CDT (2.5, 0.25, 0.025 µg/ml). After 72 h of treatment, cells were incubated with the PrestoBlue Cell Viability Reagent (1X) for 2 h at 37°C and absorbance (570 nm measurement wavelength, 600 nm reference wavelength) was read using an Infinite 200 PRO reader (TECAN). The percentage of cytotoxicity was determined by comparing results with non-treated cells.
Immunoprecipitation

10
7 HCT116 cells exposed for 24 h to 250 pg/ml of CDT wt before to be collected and lyzed in IP250
buffer (50 mM Tris-HCl pH 7.5, 250 mM NaCl, 0.05% NP40), and soluble extract was incubated with antibodies against FANCD2 from GeneTex (GTX116037) or from Novus Biologicals (NB100-182) overnight at 4°C under constant agitation. Then, 20 µl of equilibrated Protein A Magnetic Beads (Thermo Scientific) were added for 1 h before to be washed for 5 minutes three times in IP250 buffer before to proceed to immunoblots. Figure   Fig . S1 Effects on cell viability and cell cycle arrest caused by p53 deficiency on HCT116 cells exposed to CDT. 
Supplementary
B. Quantification of the XRCC4 L form / S form ratio from the Western blots presented in (A). Results
represent the mean ± SD of at least three independent experiments. Statistics were calculated by unpaired Student's t-test (* P < 0.05). independent experiments (* P < 0.05; ** P < 0.01; *** P < 0.001). B. HeLa cells treated with control or FANCD2 siRNA were exposed for 5 days to CDT wt or CDT H153A and cell viability was analyzed by crystal violet staining (* P < 0.05; ** P < 0.01; *** P < 0.001). C. Clonogenic survival of PD20 D2 and PD20 cells treated or not with 10 µM of Pifithrin-α (PFT) and exposed to CDT wt or CDT H153A . Results are the mean ± SD of at least 3 independent experiments.
Statistics were calculated by unpaired Student's t-test (** P < 0.01; *** P < 0.001).
D. Cell cycle analysis by flow-cytometry of XRCC4 +/+ MEFs non-treated (NT) or treated or not with 10 µM of Pifithrin-α (PFT) and exposed for 24 h to CDT wt (2.5 ng/ml).
E. Micronucleus frequency in XRCC4 +/+ , XRCC4 -/-, PARP1 +/+ and PARP1 -/-MEFs, PD20 D2 and PD20 cells exposure to CDT wt for 24 to 36 h. The CDT dose was 75 pg/ml for XRCC4 +/+ and XRCC4
-/-MEFs, 75 pg/ml for PARP1 +/+ and PARP1 -/-MEFs, and 2.5 pg/ml for PD20 D2 and PD20 cells. Results are the mean ± SD of 3 independent experiments.
Fig. S8
Full-length blots of the different cropped blots from this study. 
